Sign up to save your podcasts
Or
Share The Utility of Biomarkers in Patients with Cognitive Impairment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Utility of Biomarkers in Patients with Cognitive Impairment
Dr. Joseph Therriault discusses his paper, "Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOEε4, and Cognitive Impairment"
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Joseph Therriault discusses his paper, "Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOEε4, and Cognitive Impairment"
More shows like Neurology Minute
View all
JAMA Editors' Summary
129 Listeners
Neurology® Podcast
284 Listeners
NEJM This Week
318 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
487 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
86 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
77 Listeners